# Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer

Source: https://onco.cc/trials/nct06361030/  
OnCo record `nct06361030` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial in pancreatic cancer, run by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, not yet recruiting.

## Summary

Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer is a phase 2, interventional study registered as NCT06361030 by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, with a registry enrolment figure of 40 participants, started 2024-06-01 and due to reach its primary completion in 2026-06-01. Interventions recorded: surufatinib combined with gemcitabine plus nab-paclitaxel. Conditions listed: Pancreatic Cancer; Pancreatic Cancer Non-resectable; Pancreatic Ductal Adenocarcinoma, PDAC. Primary outcome: Surgical conversion rate. Pancreatic eligibility wording from the registry: "Histologically or cytologically confirmed adenocarcinoma of the pancreas". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT06361030
- Phase: 2
- Setting: An Exploratory Clinical Study of Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Patients With Locally Advanced Pancreatic Cancer
- Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Enrolled: 40

## Sources

- ClinicalTrials.gov NCT06361030: https://clinicaltrials.gov/study/NCT06361030

## Connected records

- cancers: [Locally advanced unresectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/locally-advanced-pdac/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06361030.json